Caffeine for apnea of prematurity and brain development at 11 years of age

Abstract Objective Caffeine therapy for apnea of prematurity has been reported to improve brain white matter microstructure at term‐equivalent age, but its long‐term effects are unknown. This study aimed to investigate whether caffeine affects (1) brain structure at 11 years of age, and (2) brain de...

Full description

Bibliographic Details
Main Authors: Claire E. Kelly, Wenn Lynn Ooi, Joseph Yuan‐Mou Yang, Jian Chen, Chris Adamson, Katherine J. Lee, Jeanie L. Y. Cheong, Peter J. Anderson, Lex W. Doyle, Deanne K. Thompson
Format: Article
Language:English
Published: Wiley 2018-09-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.628
id doaj-41c5fcf7ee734319bb921aeffbb472b1
record_format Article
spelling doaj-41c5fcf7ee734319bb921aeffbb472b12021-05-02T22:07:55ZengWileyAnnals of Clinical and Translational Neurology2328-95032018-09-01591112112710.1002/acn3.628Caffeine for apnea of prematurity and brain development at 11 years of ageClaire E. Kelly0Wenn Lynn Ooi1Joseph Yuan‐Mou Yang2Jian Chen3Chris Adamson4Katherine J. Lee5Jeanie L. Y. Cheong6Peter J. Anderson7Lex W. Doyle8Deanne K. Thompson9Victorian Infant Brain Studies Murdoch Children's Research Institute Melbourne AustraliaVictorian Infant Brain Studies Murdoch Children's Research Institute Melbourne AustraliaDevelopmental Imaging Murdoch Children's Research Institute Melbourne AustraliaDevelopmental Imaging Murdoch Children's Research Institute Melbourne AustraliaDevelopmental Imaging Murdoch Children's Research Institute Melbourne AustraliaVictorian Infant Brain Studies Murdoch Children's Research Institute Melbourne AustraliaVictorian Infant Brain Studies Murdoch Children's Research Institute Melbourne AustraliaVictorian Infant Brain Studies Murdoch Children's Research Institute Melbourne AustraliaVictorian Infant Brain Studies Murdoch Children's Research Institute Melbourne AustraliaVictorian Infant Brain Studies Murdoch Children's Research Institute Melbourne AustraliaAbstract Objective Caffeine therapy for apnea of prematurity has been reported to improve brain white matter microstructure at term‐equivalent age, but its long‐term effects are unknown. This study aimed to investigate whether caffeine affects (1) brain structure at 11 years of age, and (2) brain development from term‐equivalent age to 11 years of age, compared with placebo. Methods Preterm infants born ≤1250 g were randomly allocated to caffeine or placebo. Magnetic resonance imaging (MRI) was performed on 70 participants (33 caffeine, 37 placebo) at term‐equivalent age and 117 participants (63 caffeine, 54 placebo) at 11 years of age. Global and regional brain volumes and white matter microstructure were measured at both time points. Results In general, there was little evidence for differences between treatment groups in brain volumes or white matter microstructure at age 11 years. There was, however, evidence that the caffeine group had a smaller corpus callosum than the placebo group. Volumetric brain development from term‐equivalent to 11 years of age was generally similar between treatment groups. However, there was evidence that caffeine was associated with slower growth of the corpus callosum, and slower decreases in axial, radial, and mean diffusivities in the white matter, particularly at the level of the centrum semiovale, over time than placebo. Interpretation This study suggests any benefits of neonatal caffeine therapy on brain structure in preterm infants weaken over time and are not clearly detectable by MRI at age 11 years, although caffeine may have long‐term effects on corpus callosum development.https://doi.org/10.1002/acn3.628
collection DOAJ
language English
format Article
sources DOAJ
author Claire E. Kelly
Wenn Lynn Ooi
Joseph Yuan‐Mou Yang
Jian Chen
Chris Adamson
Katherine J. Lee
Jeanie L. Y. Cheong
Peter J. Anderson
Lex W. Doyle
Deanne K. Thompson
spellingShingle Claire E. Kelly
Wenn Lynn Ooi
Joseph Yuan‐Mou Yang
Jian Chen
Chris Adamson
Katherine J. Lee
Jeanie L. Y. Cheong
Peter J. Anderson
Lex W. Doyle
Deanne K. Thompson
Caffeine for apnea of prematurity and brain development at 11 years of age
Annals of Clinical and Translational Neurology
author_facet Claire E. Kelly
Wenn Lynn Ooi
Joseph Yuan‐Mou Yang
Jian Chen
Chris Adamson
Katherine J. Lee
Jeanie L. Y. Cheong
Peter J. Anderson
Lex W. Doyle
Deanne K. Thompson
author_sort Claire E. Kelly
title Caffeine for apnea of prematurity and brain development at 11 years of age
title_short Caffeine for apnea of prematurity and brain development at 11 years of age
title_full Caffeine for apnea of prematurity and brain development at 11 years of age
title_fullStr Caffeine for apnea of prematurity and brain development at 11 years of age
title_full_unstemmed Caffeine for apnea of prematurity and brain development at 11 years of age
title_sort caffeine for apnea of prematurity and brain development at 11 years of age
publisher Wiley
series Annals of Clinical and Translational Neurology
issn 2328-9503
publishDate 2018-09-01
description Abstract Objective Caffeine therapy for apnea of prematurity has been reported to improve brain white matter microstructure at term‐equivalent age, but its long‐term effects are unknown. This study aimed to investigate whether caffeine affects (1) brain structure at 11 years of age, and (2) brain development from term‐equivalent age to 11 years of age, compared with placebo. Methods Preterm infants born ≤1250 g were randomly allocated to caffeine or placebo. Magnetic resonance imaging (MRI) was performed on 70 participants (33 caffeine, 37 placebo) at term‐equivalent age and 117 participants (63 caffeine, 54 placebo) at 11 years of age. Global and regional brain volumes and white matter microstructure were measured at both time points. Results In general, there was little evidence for differences between treatment groups in brain volumes or white matter microstructure at age 11 years. There was, however, evidence that the caffeine group had a smaller corpus callosum than the placebo group. Volumetric brain development from term‐equivalent to 11 years of age was generally similar between treatment groups. However, there was evidence that caffeine was associated with slower growth of the corpus callosum, and slower decreases in axial, radial, and mean diffusivities in the white matter, particularly at the level of the centrum semiovale, over time than placebo. Interpretation This study suggests any benefits of neonatal caffeine therapy on brain structure in preterm infants weaken over time and are not clearly detectable by MRI at age 11 years, although caffeine may have long‐term effects on corpus callosum development.
url https://doi.org/10.1002/acn3.628
work_keys_str_mv AT claireekelly caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT wennlynnooi caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT josephyuanmouyang caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT jianchen caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT chrisadamson caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT katherinejlee caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT jeanielycheong caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT peterjanderson caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT lexwdoyle caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
AT deannekthompson caffeineforapneaofprematurityandbraindevelopmentat11yearsofage
_version_ 1721487071601754112